Sporanox Capsule
Product Images NDC 50458-290

2 FDA label images from Janssen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sporanox (NDC 50458-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sporanox 01)

Chemical Structure (Sporanox 01)
Chemical structure of the active ingredient itraconazole depicted in a two-dimensional molecular diagram showing its atomic composition and bonds.*
FDA Label Image

Principal Display Panel (100 mg Pouch Carton)

Principal Display Panel (100 mg Pouch Carton)
SPORANOX (itraconazole) 100 mg capsules PulsePak packaging label in a green and black design. The box states the product contains 7 pouches with 4 capsules each, intended for 7 days of treatment. The label shows dosage instructions referencing accompanying product literature and storage conditions. Janssen Pharmaceuticals, Inc. is the labeler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.